National Peroxide Ltd

National Peroxide Limited has informed the stock exchange that a Board of Directors meeting is scheduled for November 11, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. This announcement is made in compliance with SEBI Listing Regulations.

National Peroxide Limited announced that its Board of Directors has accepted the resignation of Mr. Rajiv Arora from the position of Whole-Time Director & Chief Executive Officer (CEO), effective November 2, 2026. Mr. Arora will continue until this date to ensure an orderly transition. Concurrently, the Board has approved the appointment of Mr. Vinay Divakar Jayade as the new CEO and Whole-Time Director, effective November 3, 2026, for a term of 5 years, subject to shareholder approval. Mr. Jayade will serve as CEO & Whole-Time Director (Designate) from October 1, 2026, working closely with Mr. Arora during the transition period. Mr. Jayade has confirmed he is not debarred from holding a director position by any regulatory authority.

National Peroxide Limited announced changes in its top management. Mr. Rajiv Arora has resigned as Whole-Time Director & CEO, effective November 2, 2026, to facilitate an orderly transition. The Board has approved the appointment of Mr. Vinay Divakar Jayade as the new Chief Executive Officer and Whole-Time Director, effective November 3, 2026, for a term of 5 years, subject to shareholder approval. Mr. Jayade will serve as Designate CEO & Director from October 1, 2026, working closely with Mr. Arora during the transition period. Mr. Jayade is not debarred from holding a director's office by any regulatory authority.

National Peroxide Limited announced a significant management change following a Board Meeting held on October 01, 2026. Mr. Rajiv Arora has resigned from his positions as Whole-Time Director and Chief Executive Officer (CEO), effective November 02, 2026. He will continue until this date to ensure a smooth transition. Concurrently, the Board has approved the appointment of Mr. Vinay Divakar Jayade as the new CEO and Whole-Time Director, effective November 3, 2026, for a term of 5 years, subject to shareholder approval. Mr. Jayade will serve as CEO & Whole-Time Director (Designate) from October 1, 2026, working closely with Mr. Arora during the transition period.

National Peroxide Ltd conducted its 6th Annual General Meeting (AGM) on September 29, 2026, via video conferencing. The meeting, chaired by Mr. Ness N. Wadia, commenced at 11:00 AM IST and concluded at 12:00 PM IST. Key agenda items included the adoption of the Audited Financial Statements for the fiscal year ended March 31, 2026, and the declaration of a final dividend of ₹7.00 per equity share. The company also addressed the appointment of a director retiring by rotation. All statutory registers and documents were available for electronic inspection.

National Peroxide Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure will be effective from October 01, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. This measure is in accordance with the company's Code of Conduct for trading in equity shares.

National Peroxide Ltd has issued a communication to its shareholders regarding Tax Deducted at Source (TDS) on dividends for the Financial Year 2025-26. The company's Board recommended a dividend of ₹7.00 per equity share, subject to member approval at the AGM on September 29, 2026. Shareholders are urged to update their details, including PAN, residential status, and category, by September 22, 2026, to ensure compliance with TDS provisions. The communication outlines the process and documentation required for claiming tax exemptions on dividends.

National Peroxide Ltd has announced its 6th Annual General Meeting (AGM) scheduled for September 29, 2026, to be held via Video Conferencing/Other Audio-Visual Means at 11:00 AM IST. The company has dispatched the Annual Report for the Financial Year 2025-26 along with the AGM notice to its members. The Annual Report, detailing corporate overview, CEO's message, management discussion, board of directors, statutory reports, and financial statements, is also available on the company's website. The report highlights the company's strategy focused on expanding reach, creating value, strengthening customer relationships, entering high-potential markets, and developing innovative solutions amidst a challenging global environment.

National Peroxide Limited has announced its 6th Annual General Meeting (AGM) scheduled for September 29, 2026, at 11:00 a.m. IST, to be conducted via Video Conference (VC) / Other Audio Visual Means (OAVM). The company is also distributing its Annual Report for the Financial Year 2025-26. For shareholders who have not registered their email addresses, a web-link to the Annual Report and AGM Notice is provided, in compliance with Listing Regulations. The company also reminds shareholders to update KYC details and dematerialize physical securities, providing links to relevant forms and information on their website and their Registrar and Share Transfer Agent's (RTA) website.

National Peroxide Ltd has announced its 6th Annual General Meeting (AGM) scheduled for Tuesday, September 29, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing/Other Audio-Visual Means. The company has also released its Annual Report for the Financial Year 2025-26, which includes a corporate overview, CEO's message, management discussion and analysis, board of directors' report, statutory reports, revised financial statements, and the AGM notice. The Annual Report and AGM notice have been electronically dispatched to all registered members and are also available on the company's website.